Security key
786700104
Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT)
CUSIP: 786700104
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Series A Common Stock, $0.0001 par value per share
- Total 13F shares
- 109,250
- Total 13F value
- $844,000
- Share change
- -40,511
- SEC-reported price per share
- $7.73
- Number of holders
- 1
- Value change
- -$312,964
- Number of sells
- 1
- Shares outstanding
- 31,278,271
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
SGMT full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Sagimet Biosciences Inc. SEC filings
Sagimet Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 786700104
Recent filing periods:
Ownership snapshot
Top reported holders of SGMT - Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AP11 Ltd
Disclosed value leader
Woodline Partners LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 4.9%
13D/G row: AP11 Ltd
Showing 1-6 of 15 holder rows.
Quick read
AP11 Ltd leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AP11 Ltd's linked filing trail.
Comparable ownership
Top 5
AP11 Ltd
4.9%
Woodline Partners LP
4.8%
Blue Owl Capital Holdings LP
4.3%
VANGUARD CAPITAL MANAGEMENT LLC
3.5%
MARSHALL WACE, LLP
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AP11 Ltd |
13D/G
AP11 Limited
|
4.9%
|
$5,055,597
1,504,642 shares
|
-$504,198 | 24 Jun 2025 |
| Woodline Partners LP |
13D/G
13F
Company
|
4.8%
|
$10,299,309
1,501,357 shares
|
-$7,211,088 | 30 Sep 2025 |
| Blue Owl Capital Holdings LP |
13D/G
13F
Company
|
4.3%
|
$4,527,659
1,323,877 shares
|
$0 | 31 Dec 2024 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3.5%
|
$5,741,852
1,098,919 shares
|
— | 31 Mar 2026 |
| MARSHALL WACE, LLP |
13F
Company
|
3.1%
|
$5,043,840
966,253 shares
|
— | 31 Mar 2026 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
3%
|
$4,979,404
952,996 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
109,250
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
88
Q2 2026 holders
1
Holder diff
-87
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend